Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Biktarvy3.47B46.02%
Veklury692M9.17%
Other684M9.07%
Descovy586M7.77%
Genvoya449M5.95%
Yescarta387M5.13%
Sofosbuvir/Velpatasvir385M5.10%
Trodelvy332M4.40%
Odefsey326M4.32%
Vemlidy232M3.07%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States19.44B71.68%
Europe4.31B15.89%
Other international3.37B12.42%